Development of alpha diversity across weeks towards a new TNF treatment for each IBD disease subtype. by Katrine Carlsen (5477300)

Subjects:

Community composition of samples from five individuals show clustering of samples according to individual. by Katrine Carlsen (5477300)

Subjects:

Study taxonomy. by Katrine Carlsen (5477300)

Subjects:

Microbiome profile of the most abundant phyla in one patient (Patient 1), across 12 infliximab treatments (-1 is the week before treatment, -2 the two weeks before treatment, etc). by Katrine Carlsen (5477300)

Subjects:

S5 Fig - by Katrine Carlsen (5477300)

Subjects:

Summary statistics for analysis of single family clades. by Katrine Carlsen (5477300)

Subjects:

STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

Subjects:

KO of iPLA₂γ attenuates development of albuminuria in STZ-induced diabetic nephropathy. by Andrey V. Cybulsky (4007012)

Subjects:

Control (Ctrl) STZ mice show changes in glomerular morphology. by Andrey V. Cybulsky (4007012)

Subjects:

Control (Ctrl) GECs are more susceptible to injury compared to iPLA₂γ KO GECs. by Andrey V. Cybulsky (4007012)

Subjects:

Podocyte numbers in control and iPLA₂γ KO mice (WT1-positive cells). by Andrey V. Cybulsky (4007012)

Subjects:

Primary data. by Andrey V. Cybulsky (4007012)

Subjects:

Summary of previous work. by Junyan Wang (4738518)

Subjects:

Comparison of MAP@0.5 results from experiments. by Junyan Wang (4738518)

Subjects:

YOLO11. by Junyan Wang (4738518)

Subjects:

Structure of the SCI-YOLO11 network. by Junyan Wang (4738518)

Subjects:

Comparative experimental results. by Junyan Wang (4738518)

Subjects:

The process of data collection and annotation by drones. by Junyan Wang (4738518)

Subjects:

Algorithm operation steps. by Junyan Wang (4738518)

Subjects:

Visualization of heatmaps before and after improvement. by Junyan Wang (4738518)

Subjects: